In Vivo Services Update

                                             

In This Issue
EAE Models: Multiple Sclerosis
  
Quick Links
    
Innovation
  

For information on  niche models to support orphan drug development please contact us. 

 

 

Quick Find 
  
To quickly access information on specific disease models, please refer to the "Quick Find" menus on our website .
  

Some Useful Direct Links:

Rapid Turnaround PK & MTD  

 

 

Catalog

 

We'll be happy to e-mail you our current Catalog of Drug Development Services, a convenient reference & useful resource to supplement our website. Please contact us.
 
Newsletter Archives
To view recently archived Newsletters, please click on "Newsletter" on our Homepage.
 
Washington Biotechnology, Inc. 
_____________________________________
  
Innovation . Speed . Accuracy . Dependability 
__________________________________________ 
 

EAE Models: Multiple Sclerosis

 

 

Washington Biotechnology, Inc., a leader in In Vivo preclinical testing, has full services for analysis of test article efficacy in EAE Models of human multiple sclerosis (human demyelinating disease).

 


  

Our comprehensive services include:

 

-        Models for Chronic Progressive MS (EAE MOG peptide-induced disease) and Remitting, Relapsing MS (EAE PLP peptide-induced disease).

 

-        Prophylactic and Therapeutic Protocols

 

-        Daily In Vivo Scoring and animal observations (results transmitted frequently so you see how your study is progressing)

 

-        Assessment of Spinal Cords for demyelination and inflammation

 

-        Validated Controls: FTY720 and Dexamethasone

 

-        Experienced technical staff

 

-        Rapid Scheduling: your study will start within 10 days of order

 

-        Flexible Protocols

 

-        Detailed and Comprehensive Final Reports

-         

Our technical staff is available to discuss your requirements and design a cost-beneficial study plan to best fit your drug development and budget parameters.

 
For further information on our EAE models and to receive expert recommendations on your intended study, please contact us



 

 

WASHINGTON BIOTECHNOLOGY, INC. offers:

  • All services at our U.S. facility in Baltimore, Maryland
  • Competitive Pricing
  • Rapid start-up of studies
  • Fully detailed final reports
  • Standard or custom protocols 

Specialists in vaccine and compound testing with prophylactic or therapeutic protocols for:
  • Inflammation models
  • Arthritis models
  • Cancer - xenograft, orthotopic, syngeneic 
  • Bacterial infection models (antibiotic efficacy)  

Full in vitro support services:
  • Plasma, tissue, organ collections & preservations
  • Histology
  • Cytokine assays
  • Cell counts (total and differential)
  • Clinical chemistries

And for optimal dosing selection we offer:

  • MTD
  • PK
  • Toxicity - acute and chronic
  • Our staff recommendations for formulations, dosing routes and regimens

Please contact us for expert recommendations on your intended vaccine or drug in vivo studies. Thank you.

Washington Biotechnology, Inc.
6200 Seaforth Street
Baltimore, MD 21224
USA
TEL: +1-410-633-9210
FAX: +1-410-633-9213
  
  
General Enquiries:    [email protected]